Stay updated with breaking news from Bikash Chatterjee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaceutical AI companies trump late- and early-stage biotech firms as the most appealing investment option for venture capitalists
The Board of Directors of Pharmatech Associates today announced the appointment of Sireesha Yadlapalli as chief executive officer effective June 5 2023.
The Board of Directors of Pharmatech Associatestoday announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June 5, 2023. Ms. Yadlapalli will succeed Bikash Chatterjee
New York, 29th March 2023: Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to Increased Resilience – Bikash Chatterjee, CEO of Pharmatech Associates [a USP company] forewarns that CDMO supply chains are potentially the biggest single risk to product resilien...
In line with the U.S. Pharmacopeia (USP) initiative to support and guide industry adoption of pharmaceutical continuous manufacturing (PCM), Pharmatech Associates has reached an agreement with Integra